Culprit Lesion Morphology On Oct In Stemi Vs Nstemi – A Systematic Review Of 7526 Patients,
2023
Department of Cardiology, Sreechitra Tirunal Institute of Medical Sciences and Technology (SCTIMST), Thiruvananthapuram ,India
Culprit Lesion Morphology On Oct In Stemi Vs Nstemi – A Systematic Review Of 7526 Patients, Avinash Mani, Vineeta Ojha, Harikrishnan Sivadasanpillai, Bijulal Sasidharan, Sanjay Ganapathi, Ajit Kumar Valaparambil
Journal of the Saudi Heart Association
Background Patients with STEMI are postulated to have different culprit lesion morphology compared to NSTEMI. The use of OCT in ACS can help delineate lesion morphology. The aim of this systematic review was to analyze the available data on culprit plaque morphology in ACS patients.
Methods The available literature was systematically screened for studies on culprit lesion morphology in ACS patients. Data was extracted from the selected studies and analyzed for baseline characteristics as well as culprit lesion morphology on OCT. Lesion characteristics between STEMI and NSTEMI groups were compared.
Results A total of 32 studies were selected for the …
National Heart Center/Saudi Heart Association 2023 Guidelines On The Management Of Hypertension,
2023
Department of Cardiac Sciences, King Saud University, Riyadh, Saudi Arabia
National Heart Center/Saudi Heart Association 2023 Guidelines On The Management Of Hypertension, Waleed Alhabeeb, Adel Abdulkader Tash, Mostafa Alshamiri, Mohamed Arafat, Mohammed Ali Balghith, Ali Almasood, Abdulla Eltayeb, Hossam Elghetany, Taher Hassan, Owayed Alshemmari
Journal of the Saudi Heart Association
Background: Hypertension is a highly prevalent disease in Saudi Arabia with poor control rates. Updated guidelines are needed to guide the management of hypertension and improve treatment outcomes. Methodology: A panel of experts representing the National Heart Center (NHC) and the Saudi Heart Association (SHA) reviewed existing evidence and formulated guidance relevant to the local population, clinical practice and the healthcare system. The recommendations were reviewed to ensure scientific and medical accuracy. Recommendations: Hypertension was defined and a new classification was proposed as relevant to the Saudi population. Recommendations on diagnosis, clinical evaluation, cardiovascular assessment were detailed, along with guidance …
Better Survival In Morbidly Obese Patients With Atrial Fibrillation Treated With Non-Vitamin K-Dependent Oral Anticoagulants,
2023
Cardiology Clinical Pharmacy Department, Prince Sultan Cardiac Center, Riyadh, KSA
Better Survival In Morbidly Obese Patients With Atrial Fibrillation Treated With Non-Vitamin K-Dependent Oral Anticoagulants, Monirah A. Albabtain, Zaid Alanazi, Nawaf Al Mutairi, Yahya Al Hebaishi, Ola Alyafi, Haneen Alghasoon, Amr A. Arafat
Journal of the Saudi Heart Association
Background: The efficacy and safety of non-vitamin K-dependent anticoagulants (NOAC) are not well investigated in the obese population, and fixed dosing could lead to under-anticoagulation. Our objective was to evaluate the effect of obesity on anticoagulation outcomes and survival in non-valvular atrial fibrillation (AF) patients. Methods: We enrolled 755 patients who required anticoagulation for AF from 2015 to 2016. We grouped the patients into four groups. Group 1 (n= 297) included patients with BMI< 40 Kg/m2 treated with NOACs, Group 2 (n= 358) included patients on warfarin with BMI< 40 Kg/m2, Group 3 (n= 57) had patients on NOACs with BMI≥ 40 Kg/m2 and Group 4 (n= 43) included patients on warfarin and BMI≥ 40 Kg/m2. Study outcomes were the composite endpoint of stroke, bleeding, and survival. Results: Competing risk regression showed that stroke and bleeding were not affected by obesity or treatment (SHR: 1.09 (95% CI: 0.79- 1.51); P= 0.62). Older age was the predictor of stroke/bleeding (HR:1.03 (95% CI:1.01- 1.06); P= 0.02). Predictors of mortality were heart failure (HR:2.23 (95% CI:1.25- 3.97); P= 0.007), lower creatinine clearance (HR: 0.98 (95% CI:0.97- 0.98): P< 0.001), non-obese patients on warfarin (HR:3.51 (95%CI:1.6- 7.7): P=0.002) and obese patients on warfarin (HR: 6.7 (95% CI:2.51- 17.92); P< 0.001). Conclusion: NOACs could have a similar risk profile to warfarin in obese and non-obese patients with non-valvular AF but could have better survival. Larger randomized trials are recommended.
A Case Of Congenital Coronary Sinus Ostial Atresia With Persistent Left Superior Vena Cava,
2023
Maine Medical Center
A Case Of Congenital Coronary Sinus Ostial Atresia With Persistent Left Superior Vena Cava, Laura Onderko, Thomas A. Miller, Sean Novak, Jeffrey Rosenblatt
Journal of Maine Medical Center
Introduction: The coronary sinus is responsible for venous drainage of the heart. Congenital anomalies of the coronary sinus are rare and typically associated with other anomalies, such as atrial septal defects or other congenital heart malformations.
Clinical Findings: We present a case of incidentally found atresia of the coronary sinus ostium with associated persistent left superior vena cava. This case involved a 52-year-old patient who initially presented with a supraventricular tachycardia and elevated troponin.
Clinical Course: The patient underwent cardiac workup with a coronary computed tomographic angiography scan. This scan showed no obstructive coronary artery disease, but did show congenital …
Left Bundle Branch Area Pacing From A Femoral Approach In A Patient Without Superior Access,
2023
Hospital of the University of Pennsylvania
Left Bundle Branch Area Pacing From A Femoral Approach In A Patient Without Superior Access, Bishnu Dhakal, Stuart Prenner, Edward Magargee, Danesh Modi, Colin Movsowitz, Robert Schaller
Division of Cardiology Faculty Papers
Limited venous access and lateral left ventricular scar are impediments to traditional cardiac resynchronization therapy. We present a case where placement of an implantable cardioverter-defibrillator from a femoral approach while using left bundle branch area pacing led to clinical improvement. (Level of Difficulty: Intermediate.)
Complications Of Cardiopulmonary Bypass From An Anesthesia Perspective: A Clinical Review,
2023
Grand Strand Regional Medical Center
Complications Of Cardiopulmonary Bypass From An Anesthesia Perspective: A Clinical Review, Alex Roberts, Elizabeth C. Duncan, Paul Hargrave, David Redding Kingery, Josh Barnes, Derek L. Horstemeyer, Russell F. Stahl
HCA Healthcare Journal of Medicine
Cardiopulmonary bypass (CPB) is frequently used for open heart surgery and other procedures that utilize temporary substitution or support of heart and lung function. While it is widely accepted as the predominant method to carry out these procedures, it is not without possible complications. CPB can be seen as the ultimate “team sport” as it includes and is dependent on contributions from multiple professionals including anesthesiologists, cardiothoracic surgeons, and perfusion technicians. In this clinical review paper, we examine possible complications of CPB, primarily from the perspective of the anesthesiologist, and how to troubleshoot them if they arise, which often requires …
Case Of Bilateral Atrial Myxomas In Carney Syndrome,
2023
Cardiac Surgery Resident, Cardiac Surgery Department, Saud Al-Babtain Cardiac Center, Dammam, Saudi Arabia
Case Of Bilateral Atrial Myxomas In Carney Syndrome, Anwar Abdullatif Alhulaibi, Abdulrahman Mashatel Alruwaili, Zahra Mohammed Albahar, Wiam Tagelsir Abdelsalam, Mohamed Abdelaziz Elasheri, Abdullah Saad Alotaibi
Journal of the Saudi Heart Association
Carney complex is rare neoplastic disorder. Intracardiac myxoma presenting the most common non-cutaneous lesions in this complex. We are reporting a 31-year-old Saudi female known case of Carney complex presented with asymptomatic biatrial myxoma that was identified on routine transthoracic echocardiogram, and was successfully excised. However, these patients need a careful surveillance in order to detect any new masses and prevent their complications.
Preserving The Patients’ Lifeline: Reducing Complications By Adopting A Vascular Access Assessment Improvement Process,
2023
Providence
Preserving The Patients’ Lifeline: Reducing Complications By Adopting A Vascular Access Assessment Improvement Process, Ana Lopez Franco
Providence Nursing Research Conference 2023 – Present
No abstract provided.
Prevention Of Doxorubicin-Induced Cardiotoxicity By A Coumestan Analogue, Psoralidin,
2023
Noorda College of Osteopathic Medicine
Prevention Of Doxorubicin-Induced Cardiotoxicity By A Coumestan Analogue, Psoralidin, Mujtaba H. Shah, Myia Aiges, Kota V. Ramana
Annual Research Symposium
Natural phenolic compound Psoralidin limits cardiotoxicity associated with Doxorubicin
Severe Left Ventricular Dysfunction Earlier After Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Predictors And In-Hospital Outcome– A Middle Eastern Tertiary Center Experience,
2023
Cardiac center, King Abdullah Medical City- Makkah, Saudi Arabia
Severe Left Ventricular Dysfunction Earlier After Acute Myocardial Infarction Treated With Primary Percutaneous Coronary Intervention: Predictors And In-Hospital Outcome– A Middle Eastern Tertiary Center Experience, Sheeren Khaled, Ghada Shalaby
Journal of the Saudi Heart Association
Improving or maintaining heart function following percutaneous coronary intervention (PPCI) is not identified in all patients. Our aim in the current study is to investigate the prevalence, factors associated with early left ventricular (LV) dysfunction following successful revascularization of myocardial infarction patients
Methods: A single-center retrospective study included 2863 myocardial infarction patients who were admitted to our center and treated with successful PPCI
Results: Out of 2863 consecutive patients who underwent PPCI from May 2018 to August 2021, 1021 (36%) developed server LV dysfunction. They showed a higher history rate of ischemic heart disease and previous revascularization before AMI (P=0.05 …
Management Of Patients With Refractory Cardiogenic Shock And Cardiointestinal Syndrome With Impella 5.5 As Bridge To Decision: Case Series,
2023
University of Texas Health Science Center at Houston
Management Of Patients With Refractory Cardiogenic Shock And Cardiointestinal Syndrome With Impella 5.5 As Bridge To Decision: Case Series, Ismael A. Salas De Armas, Bindu Akkanti, Amanda Bergeron, Anju Bhardwaj, Kha Dinh, Ali Shirafkan, Jayeshkumar A. Patel, Manish K. Patel, Carlos R. Manrique Neira, Igor D. Gregoric, Biswajit Kar, Mehmet H. Akay
Journal of Shock and Hemodynamics
Patients with advanced heart failure require multi-system management as a majority succumb to end-organ dysfunction, including gastrointestinal sequelae. Temporizing measures, such as early mechanical circulatory support, can assist in the recovery of patients with acute cardiogenic shock. The temporary support can improve patient characteristics to enable future definitive heart failure therapies such as durable left ventricular assist devices and orthotopic heart transplantation. We present two cases of cardiogenic shock that were successfully bridged with an Impella 5.5 (Abiomed). The management enabled the patients to recover from reversible cardiointestinal syndrome and undergo successful definitive therapies.
Revascularization In Cardiogenic Shock: Residual Syntax Score And Chronic Total Occlusions,
2023
Cleveland Clinic, Cleveland, OH
Revascularization In Cardiogenic Shock: Residual Syntax Score And Chronic Total Occlusions, Venugopal Menon
Journal of Shock and Hemodynamics
The residual syntax score (rSS) is strongly associated with outcomes in patients with stable coronary artery disease. In patients with acute myocardial infarction-associated cardiogenic shock (AMI-CS), the correlation or association of the rSS, mortality risk, and revascularization strategy has not yet been elucidated and needs more investigation. The SHOCK trial demonstrated that patients with left main and severe triple-vessel disease, who underwent coronary artery bypass grafts, had improved outcomes and higher 1-year survival rates than those with initial medical stabilization. However, it is unclear which is the superior technique for achieving complete revascularization. In contrast to the SHOCK trial’s results, …
Covid-19 Induced Right Ventricular Failure And Right Ventricular Assist Device Support,
2023
University of Arizona
Covid-19 Induced Right Ventricular Failure And Right Ventricular Assist Device Support, Marvin Slepian M.D.
Journal of Shock and Hemodynamics
COVID-19, while primarily recognized for its pulmonary and systemic manifestations, afflicts the cardiovascular system through various abnormalities. Notably, right ventricular (RV) involvement leading to dysfunction and failure is a manifestation seen in up to 20% of severe COVID patients. RV severity correlates with overall COVID severity, serving as a prognostic marker. Data review reveals that RV failure was largely underdiagnosed, particularly early on in the pandemic. The therapy approach for RV failure in patients with COVID should focus on supporting overall RV perfusion pressure, maintaining sinus rhythm, optimizing RV loading conditions and contractility, and addressing anticoagulation and thrombus-related conditions. Beyond …
Right Ventricular Hemodynamics In Covid-19 Patients,
2023
Emory University School of Medicine, Atlanta, GA
Right Ventricular Hemodynamics In Covid-19 Patients, Steven Hollenberg
Journal of Shock and Hemodynamics
The right ventricle is highly sensitive to afterload, and pulmonary compromise can increase pulmonary vascular resistance and lead to right ventricular dysfunction. Pulmonary hypertension can also be exacerbated by mechanical ventilation. Patients with COVID-19 pneumonia and respiratory failure, especially those ventilated with positive end-expiratory pressure, are prone to pulmonary hypertension. Understanding their right ventricular hemodynamics can have therapeutic and prognostic implications.
Current And Emerging Therapies For Atherosclerotic Cardiovascular Disease Risk Reduction In Hypertriglyceridemia,
2023
Georgetown University
Current And Emerging Therapies For Atherosclerotic Cardiovascular Disease Risk Reduction In Hypertriglyceridemia, Reed Mszar, Sarah Bart, Alexander Sakers, Daniel Soffer, Dean G. Karalis
Division of Cardiology Faculty Papers
Hypertriglyceridemia (HTG) is a prevalent medical condition in patients with cardiometabolic risk factors and is associated with an increased risk of atherosclerotic cardiovascular disease (ASCVD), if left undiagnosed and undertreated. Current guidelines identify HTG as a risk-enhancing factor and, as a result, recommend clinical evaluation and lifestyle-based interventions to address potential secondary causes of elevated triglyceride (TG) levels. For individuals with mild to moderate HTG at risk of ASCVD, statin therapy alone or in combination with other lipid-lowering medications known to decrease ASCVD risk are guideline-endorsed. In addition to lifestyle modifications, patients with severe HTG at risk of acute pancreatitis …
Results Of Surgical Ablation For Atrial Fibrillation In Patients With Rheumatic Heart Disease,
2023
King Saud University College of Medicine
Results Of Surgical Ablation For Atrial Fibrillation In Patients With Rheumatic Heart Disease, Turki B. Albacker, Sultan Alaamro, Abdulaziz M Alhothali, Amr A Arafat, Khaled D Algarni, Ahmed Eldemerdash, Bakir M Bakir
Journal of the Saudi Heart Association
Background There is conflicting evidence regarding the success of the Maze procedure to restore sinus rhythm in patients with rheumatic heart disease. Hence, the aim of our study was to describe the results of surgical ablation for atrial fibrillation in patients with rheumatic heart disease undergoing cardiac surgery. Methods This is a retrospective study that included adult patients with rheumatic heart disease who underwent surgical ablation for atrial fibrillation. The ablation lesions were performed using monopolar radiofrequency ablation in all patients. Results Fifty-seven consecutive patients were included in the study. Cox Maze IV was performed in 44 patients (77%), while …
Coronary Flow And Unloading In Acute Myocardial Infarction Shock,
2023
Icahn School of Medicine at Mount Sinai
Coronary Flow And Unloading In Acute Myocardial Infarction Shock, Kiyo Ishikawa
Journal of Shock and Hemodynamics
In patients with cardiogenic shock that undergo successful coronary intervention, there are still factors complicating myocardial recovery. There is room for improvement in coronary flow using mechanical circulatory devices, specifically by left ventricular unloading. This idea was further explored in a research study using pigs. Results showed that subjects with acute myocardial infarction who have reduced cardiac contractility and/or high diastolic pressure would benefit from support strategies targeting left ventricular unloading.
Reducing The Risk Of Mortality In Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review,
2023
George Washington University
Reducing The Risk Of Mortality In Chronic Obstructive Pulmonary Disease With Pharmacotherapy: A Narrative Review, Matthew Mintz, Igor Barjaktarevic, Donald A. Mahler, Barry Make, Neil Skolnik, Barbara Yawn, Bree Zeyzus-Johns, Nicola A. Hanania
Abington Jefferson Health Papers
In 2020, chronic obstructive pulmonary disease (COPD) was the fifth leading cause of death in the United States excluding COVID-19, and its mortality burden has been rising since the 1980s. Smoking cessation, long-term oxygen therapy, noninvasive ventilation, and lung volume reduction surgery have had a beneficial effect on mortality; however, until recently, the effects of pharmacologic therapies on all-cause mortality have been unclear. Inhaled pharmacologic treatments for patients with COPD include combinations of long-acting muscarinic receptor antagonists (LAMAs), long-acting-β2-agonists (LABAs), and inhaled corticosteroids (ICS). The recent IMPACT and ETHOS clinical trials reported mortality benefits with ICS/LAMA/LABA triple therapy compared with …
What Did We Learn About Vads In 2022?,
2023
Indiana University
What Did We Learn About Vads In 2022?, Maya Guglin
The VAD Journal
This is our 9th annual literature review on mechanical circulatory support devices. Our previous reports were well received by the readers.
In this paper, we summarized the most interesting and important, from our standpoint, publications from 2022. There may be some slight overlap with the end of 2021 because some papers were published online first, and the year of the publication changed when they became available in print.
For the sixth time, we wrote a section on extracorporeal membrane oxygenation (ECMO) which primarily addresses new developments in veno-arterial ECMO.
Readers who wish to supplement this review, argue with the …
Old But Not Vain : Two Cases Of Refractory Polymorphic Ventricular Tachycardia Associated With Coronary Artery Disease Successfully Treated With Quinidine,
2023
Department of Medicine & Geriatrics, Kwong Wah Hospital, HKSAR
Old But Not Vain : Two Cases Of Refractory Polymorphic Ventricular Tachycardia Associated With Coronary Artery Disease Successfully Treated With Quinidine, Tit-Kei Ng, Tommy King-Him Ma, Chi-Chun Au, Janice Woon-Yan Wong, Jenny Nga-Lai Chow, Andrew Vincent Li, Adrian Yin-Cheung Luk, Sze-Wah Lai, Candy Ming-Yan Cheuk, Jaclyn Chi-Lin Chan, Li-Wah Tam
Journal of the Hong Kong College of Cardiology
Post myocardial infarct polymorphic Ventricular Tachycardia (VT) triggered by injured Purkinje fibres can cause VT storms that are refractory to various treatment even after successful reperfusion or revascularization. We reported such recurrent polymorphic VT in two post myocardial infarct patients after Percutaneous Coronary Intervention. Both of them responded readily to Quinidine. We also discussed the pathophysiology of this arrhythmia and the treatment option of it, namely catheter ablation and antiarrhythmics